MICHAEL PERRY - 07 Jan 2022 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/ Michael Perry
Issuer symbol
ARWR
Transactions as of
07 Jan 2022
Transactions value $
$0
Form type
4
Filing time
07 Jan 2022, 19:12:42 UTC
Previous filing
04 Jan 2022
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +6.4K +7.49% $0.00 91.9K 07 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.